Valicenti Advisory Services Inc. Makes New $4.12 Million Investment in GE HealthCare Technologies Inc. $GEHC

Key Points

• Valicenti Advisory Services Inc. has made a significant new investment of approximately $4.12 million in GE HealthCare Technologies, acquiring 55,557 shares during the second quarter.
• GE HealthCare Technologies outperformed analyst expectations in its recent earnings report, achieving $1.06 EPS and a revenue of $5 billion for the quarter, compared to estimates of $0.91 EPS and $4.96 billion in revenue.
• The company announced a quarterly dividend of $0.035 per share set to be paid on November 14th, representing an annualized yield of 0.2% and a payout ratio of 2.87%.

Valicenti Advisory Services Inc. purchased a new position in GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm purchased 55,557 shares of the company's stock, valued at approximately $4,115,000.

Other institutional investors have also added to or reduced their stakes in the company. N.E.W. Advisory Services LLC bought a new stake in shares of GE HealthCare Technologies during the 1st quarter valued at $25,000. Bogart Wealth LLC raised its position in shares of GE HealthCare Technologies by 260.0% during the 1st quarter. Bogart Wealth LLC now owns 342 shares of the company's stock valued at $28,000 after purchasing an additional 247 shares during the period. Stonebridge Financial Group LLC raised its position in shares of GE HealthCare Technologies by 165.7% during the 1st quarter. Stonebridge Financial Group LLC now owns 356 shares of the company's stock valued at $29,000 after purchasing an additional 222 shares during the period. Ameriflex Group Inc. bought a new stake in shares of GE HealthCare Technologies during the 4th quarter valued at $31,000. Finally, Olde Wealth Management LLC bought a new stake in shares of GE HealthCare Technologies during the 1st quarter valued at $35,000. 82.06% of the stock is currently owned by institutional investors.

GE HealthCare Technologies Stock Performance

Shares of NASDAQ:GEHC opened at $72.46 on Friday. GE HealthCare Technologies Inc. has a 52 week low of $57.65 and a 52 week high of $94.80. The stock has a market capitalization of $33.08 billion, a P/E ratio of 14.85, a PEG ratio of 2.73 and a beta of 1.13. The firm has a fifty day simple moving average of $74.35 and a two-hundred day simple moving average of $72.85. The company has a quick ratio of 0.93, a current ratio of 1.16 and a debt-to-equity ratio of 0.85.

GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last released its quarterly earnings results on Wednesday, July 30th. The company reported $1.06 EPS for the quarter, topping analysts' consensus estimates of $0.91 by $0.15. GE HealthCare Technologies had a net margin of 11.22% and a return on equity of 23.93%. The firm had revenue of $5 billion during the quarter, compared to analysts' expectations of $4.96 billion. During the same period in the previous year, the company earned $1.00 EPS. The firm's revenue for the quarter was up 3.5% compared to the same quarter last year. GE HealthCare Technologies has set its FY 2025 guidance at 4.430-4.630 EPS. On average, analysts expect that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current fiscal year.

GE HealthCare Technologies Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, November 14th. Investors of record on Friday, October 24th will be issued a dividend of $0.035 per share. The ex-dividend date is Friday, October 24th. This represents a $0.14 dividend on an annualized basis and a yield of 0.2%. GE HealthCare Technologies's dividend payout ratio (DPR) is presently 2.87%.

Wall Street Analysts Forecast Growth

GEHC has been the topic of several recent analyst reports. Citigroup raised their price objective on shares of GE HealthCare Technologies from $89.00 to $93.00 and gave the company a "buy" rating in a research report on Thursday, July 31st. Zacks Research upgraded shares of GE HealthCare Technologies from a "hold" rating to a "strong-buy" rating in a research report on Thursday, August 28th. Wall Street Zen downgraded shares of GE HealthCare Technologies from a "buy" rating to a "hold" rating in a research report on Saturday, September 20th. BTIG Research restated a "buy" rating on shares of GE HealthCare Technologies in a research report on Monday, July 14th. Finally, Morgan Stanley set a $74.00 target price on shares of GE HealthCare Technologies in a research note on Thursday, September 18th. One investment analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating and two have assigned a Hold rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and an average price target of $88.40.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.

Want to see what other hedge funds are holding GEHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.